Table 1 Demographic and clinical data and scores of the five CHAQ versions of patients and healthy controls.
JIA | Healthy | p-value | |
|---|---|---|---|
n | 89 | 22 | |
Age (years) | 11.9 (2.7) | 12.0 (2.7) | 0.67 |
Sex (m/f) | 19/70 | 12/10 | |
Diagnosis (n =) | |||
PA | 40 | ||
SA | 10 | ||
PO | 17 | ||
EO | 9 | ||
OL | 6 | ||
Missing | 7 | ||
Disease duration (years) | 5.4 (3.6) | ||
Disease activity (n = (%)) | |||
Active | 38 (43) | ||
Remission | 49 (55) | ||
Missing | 2 (2) | ||
Medication (n = (%)) | |||
None | 14 (16) | ||
NSAID | 43 (48) | ||
MTX | 46 (52) | ||
Prednisolone | 9 (10) | ||
Biologicals | 24 (27) | ||
Joint Involvement (median (IQR)) | 10 (10-30) | ||
VAS Pain | 2.7 (0-9.5) | ||
VAS GA | 2.5 (0-10) | ||
CHAQ30orig | 0.38 (0-2.13) |